BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostallari E, Valainathan S, Biquard L, Shah VH, Rautou PE. Role of extracellular vesicles in liver diseases and their therapeutic potential. Adv Drug Deliv Rev 2021;175:113816. [PMID: 34087329 DOI: 10.1016/j.addr.2021.05.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Guixé-Muntet S, Biquard L, Szabo G, Dufour JF, Tacke F, Francque S, Rautou PE, Gracia-Sancho J. Review article: vascular effects of PPARs in the context of NASH. Aliment Pharmacol Ther 2022;56:209-23. [PMID: 35661191 DOI: 10.1111/apt.17046] [Reference Citation Analysis]
2 Chu Q, Li J, Chen J, Yuan Z. HBV induced the discharge of intrinsic antiviral miRNAs in HBV-replicating hepatocytes via extracellular vesicles to facilitate its replication. J Gen Virol 2022;103. [PMID: 35604380 DOI: 10.1099/jgv.0.001744] [Reference Citation Analysis]
3 Sánchez-Rodríguez MB, Téllez É, Casulleras M, Borràs FE, Arroyo V, Clària J, Sarrias MR. Reduced Plasma Extracellular Vesicle CD5L Content in Patients With Acute-On-Chronic Liver Failure: Interplay With Specialized Pro-Resolving Lipid Mediators. Front Immunol 2022;13:842996. [PMID: 35330909 DOI: 10.3389/fimmu.2022.842996] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 van Niel G, Gazeau F, Wilhelm C, Silva AKA. Technological and translational challenges for extracellular vesicle in therapy and diagnosis. Adv Drug Deliv Rev 2021;179:114026. [PMID: 34710528 DOI: 10.1016/j.addr.2021.114026] [Reference Citation Analysis]